|
Abbott Laboratories - Medical Equipment - Deals and Alliances Profile
|
Features of this market research: | 130 pages | |||||||||
| About this market survey: |
Abbott Laboratories - Medical Equipment - Deals and Alliances Profile
Summary
Global Market Direct’s Abbott Laboratories - Medical Equipment - Deals and Alliances Profile is an essential source for .....
Abbott Laboratories - Medical Equipment - Deals and Alliances Profile Summary Global Market Direct’s Abbott Laboratories - Medical Equipment - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company’s major recent financial deals. Abbott Laboratories (Abbott) is a global health care company. It is principally engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products along with pharmaceuticals, diagnostics and nutritional products. The company principal products include prescription pharmaceuticals, nutritional products, diagnostic testing products and vascular products. Its operations are spread across more than 130 countries worldwide. Abbott is headquartered in Abbott Park, Illinois, the US. And More inside the report… Recent Developments Dec 23, 2009: Impax Initiates Patent Challenge Related To Tricor Tablets Dec 14, 2009: Abbott To Acquire Starlims Technologies Dec 03, 2009: Abbott Lays Off About 80 Jobs At Its Temecula Factory, California Scope - Provides key company information for business intelligence needs - Gives information on the company’s major recent financial deals including mergers & acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships. - Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement. Reasons to buy - A quick “one-stop-shop” to understand the company. - Support sales activities by understanding your customers’ businesses. - Qualify prospective partners and suppliers. - Understand and respond to your competitors’ business structure, strategy and prospects through. - Understanding the key deals which have shaped the company. Report Highlights The following companies are the major competitors of Abbott Laboratories: St. Jude Medical, Inc. Bayer HealthCare AG Boehringer Ingelheim GmbH Eli Lilly and Company Becton, Dickinson and Company Siemens Healthcare Edwards Lifesciences Corporation Medtronic, Inc. F. Hoffmann-La Roche Ltd. Cordis Corporation [Fade out the market survey infos] |
|||||||||||
|
Table of Contents Table of Contents 2 List of Tables 6 List of Figures 7 Abbott Laboratories, Medical Equipment, Deals By Year, 2004 to YTD 2010 8 Abbott Laboratories, Medical Equipment Deals By Type, 2004 to YTD 2010 9 Abbott Laboratories, Medical Equipment, Deals By Region, 2004 to YTD 2010 10 Abbott Laboratories, Medical Equipment, Deals By Market, 2004 to YTD 2010 11 Abbott Laboratories, Medical Equipment, Deals Summary, 2004 to YTD 2010 12 Abbott Laboratories, Medical Equipment, Deal Details 15 Asset Purchase 15 Abbott Laboratories Acquires Vascular Business Of Guidant From Boston Scientific 15 Advanced Medical Optics Acquires Surgical Ophthalmology Business From Pfizer 16 Venture Financing 17 Evalve Secures $60 Million In Series D Financing 17 Ovalis Secures $6.6 Million In Series B Funding 19 Optobionics Secures $5 Million In Series D-1 Financing 20 Partnerships 21 Prodesse Enters Into A licensing Agreement With Abbott Laboratories 21 Fujirebio Diagnostics Signs Licensing Agreement With Abbott Laboratories 22 Rubicon Genomics Enters Into An Agreement With Abbott Laboratories 23 Advanced Medical Optics Enters Into An Agreement With Alcon 24 Advanced Medical Optics Enters Into An Agreement With Bausch & Lomb 25 Advanced Medical Optics Signs An Agreement With Carl Zeiss Meditec 26 Epigenomics Signs An Agreement With Abbott Laboratories 27 MacroArray Technologies Enters Into A License Agreement With Abbott 28 Abbott Laboratories Enters Into Licensing Agreement With Advanced Life Science Institute 29 Affymetrix Enters Into Licensing Agreement With Abbott 30 Abbott Laboratories Enters Into Licensing Agreement With Bayer Healthcare 31 Abbott Laboratories Enters Into Licensing Agreement With Nephromics 32 Abbott Laboratories Enters Into Licensing Agreement With BioCurex 33 Abbott Laboratories Enters Into Licensing Agreement With Cleveland Clinic 34 Calypte Biomedical Enters Into An Agreement With Abbott Laboratories 35 Advanced Medical Optics Signs An Agreement With Quest Vision Technologies 36 Abbott Laboratories Enters Into An Agreement With BG Medicine 37 Coherex Medical Enters Into Distribution Agreement With Abbott Laboratories 38 Health Discovery Signs An Agreement With Abbott Laboratories 39 Celera Enters Into An Agreement With Abbott Laboratories 40 Abbott Laboratories Extends Its Distribution Agreement With Axis-Shield 41 Smiths Medical Enters Into An Agreement With Abbott Laboratories 42 Luminex Enters Into A Partnership Agreement With Abbott Laboratories 43 Abbott Laboratories Signs An Agreement With Medica 44 BioView Enters Into An Agreement With Abbott Molecular 45 Abbott Laboratories Enters Into Distribution Agreement With Verax 46 BioVisioN Enters Into Research Agreement With Abbott Laboratories 47 Abbott Laboratories Enters Into An Agreement With Inpeco 48 Nihon Kohden Enters Into Co-Marketing Agreement With Abbott Laboratories 49 Abbott Laboratories Enters Into Co-Marketing Agreement With OraSure 50 Abbott Laboratories Signs An Agreement With Biogenex Laboratories 51 Advanced Medical Optics Enters Into An Agreement With CooperVision 52 Advanced Medical Optics Signs An Agreement With OPHTEC USA 53 Abbott Laboratories Signs An Agreement With Artus 54 Abbott Laboratories Signs An Agreement With Atria Genetics 55 Abbott Laboratories Enters Into An Agreement With Europroteome 56 Equity Offering 57 NeoGenomics Completes Private Placement Of $4.8 Million 57 Divestiture - Company 58 Zimmer Holdings Acquires Abbott Spine From Abbott Laboratories 58 Divestiture - Assets 59 Inverness Medical Innovations Acquires Rapid Diagnostics Assets From Abbott Laboratories 59 Inverness Medical Acquires Determine Business From Abbott Laboratories 60 Debt Offering 61 Abbott Laboratories Completes Public Offering Of 5.125% Notes For $2,000 Million 61 Abbott Laboratories Completes Public Offering Of 6% Notes For $1,000 Million 62 Abbott Laboratories Completes Public Offering Of Notes Due 2012 For $1,000 Million 63 Abbott Laboratories Completes Public Offering Of Notes Due 2017 For $1,500 Million 64 Abbott Laboratories Completes Public Offering Of Notes Due 2037 For $1,000 Million 65 Advanced Medical Optics Completes Private Placement Of $250 Million 66 Advanced Medical Optics Completes Private Placement Of $500 Million 67 Abbott Laboratories Completes Public Offering Of 5.375% Notes For $500 Million 68 Abbott Laboratories Completes Public Offering Of Notes Due 2011 For $1,500 Million 69 Abbott Laboratories Completes Public Offering Of Notes Due 2016 For $2,000 Million 70 Advanced Medical Optics Completes Private Placement Of $150 Million 72 Abbott Laboratories Completes Public Offering Of Notes Due 2009 For $500 Million 73 Advanced Medical Optics Completes Private Placement Of $350 Million 74 Abbott Laboratories Completes Public Offering Of Notes Due 2014 For $500 Million 75 Abbott Laboratories Completes Public Offering Of Notes Due 2011 For $500 Million 76 Acquisition 77 Abbott Laboratories Completes Acquisition Of Evalve 77 Abbott Laboratories Completes Acquisition Of Visiogen 78 Abbott Laboratories Acquires Advanced Medical Optics 79 Abbott Laboratories Acquires Ibis Biosciences From Isis Pharmaceuticals 81 Advanced Medical Optics Acquires Intralase 82 Advanced Medical Optics Acquires Wavefront Sciences 84 Advanced Medical Optics Acquires Quest Vision Technologies 85 Advanced Medical Optics Acquires VISX 86 Abbott Laboratories Acquires Spine Next 87 Abbott Laboratories Acquires TheraSense 88 Abbott Laboratories Acquires i-STAT 89 Key Competitors 90 Key Employees 90 Locations And Subsidiaries 92 Head Office 92 Other Locations & Subsidiaries 92 Recent Developments 95 Strategy And Business Planning 95 Jun 15, 2009: UCSF, Abbott Laboratories To Launch Viral Diagnostics And Discovery Center At Mission Bay, California 95 Feb 26, 2009: Abbott Opens New Manufacturing Facility In Singapore 96 Jan 20, 2009: Abbott Opens New Research Laboratory In Singapore 96 Jan 12, 2009: Abbott To Acquire Advanced Medical Optics 97 Oct 09, 2008: Abbott Opens New Research Facility And Pilot Plant In Ludwigshafen 97 Jul 11, 2007: Abbott Announces Termination Of Contract With GE 97 Apr 10, 2007: Abbott Opens New Biotechnology Manufacturing Unit in Puerto Rico 98 Financial Announcements 98 Jan 27, 2010: Abbott Reports Net Earnings Of $5.7 Million In 2009 98 Oct 14, 2009: Abbott Reports Net Earnings Of $1.5 Billion In Q3 2009 99 Jul 15, 2009: Abbott Reports Net Earnings Of $1.29 Billion For Q2 2009 100 Apr 15, 2009: Abbott Reports Net Earnings Of $1.4 Billion For Q1 2009 101 Feb 20, 2009: Abbott Laboratories Declares 11% Increase In Quarterly Dividend 103 Jan 21, 2009: Abbott Reports 2008 Results 103 Jan 12, 2009: Abbott Provides Full-Year Earnings Guidance For 2009 105 Dec 18, 2008: Abbott To Declare 2008 Results 105 Dec 12, 2008: Abbott Declares Quarterly Dividend 105 Nov 26, 2008: Abbott Spends $1.8 Million On Lobbying In 3Q 2008 105 Oct 15, 2008: Abbott Reports 3Q 2008 Results 106 Sep 19, 2008: Abbott To Declare 3Q 2008 Results 107 Sep 12, 2008: Abbott Declares Quarterly Dividend 107 Aug 04, 2008: Abbott Spends $1 Million On Lobbying In 2Q 2008 107 Jul 16, 2008: Abbott Reports 2Q 2008 Results 107 Jun 30, 2008: Abbott To Declare Q2 2008 Results 109 Jun 06, 2008: Abbott Declares Quarterly Dividend 109 Apr 16, 2008: Abbott Declares Quarterly Dividend 109 Apr 16, 2008: Abbott Declares Q1 2008 Results 109 Apr 01, 2008: Abbott To Declare Q1 2008 Results 110 Feb 14, 2008: Abbott India Declares Fiscal 2007 Results 110 Jan 23, 2008: Abbott Declares Q4 2007 Results 110 Jan 03, 2008: Abbott To Declare Q4 And Year-End 2007 Results 111 Dec 14, 2007: Abbott Declares Quarterly Dividend 111 Oct 17, 2007: Abbott Declares Quarterly Dividend 111 Oct 17, 2007: Abbott Declares Q3 2007 Results 111 Jul 18, 2007: Abbott Reports Q2 2007 Results 112 Jun 21, 2007: Abbott India Declares Q2 Fiscal 2007 Results 112 Jun 14, 2007: Abbott Declares Quarterly Dividend 113 Apr 18, 2007: Abbott Reports Q1 2007 Results 113 Apr 18, 2007: Abbott Declares Quarterly Dividend 113 Mar 29, 2007: Abbott India Declares Q1 Fiscal 2007 Results 113 Jan 24, 2007: Abbott Reports Q4 2006 Results 114 Jan 24, 2007: Abbott Declares Quarterly Dividend 114 Oct 18, 2006: Abbott Reports Q3 2006 Results 114 Oct 18, 2006: Abbott Declares Quarterly Dividend 115 Oct 18, 2006: Abbott Announces Share Repurchase Program 115 Jul 19, 2006: Abbott Reports Q2 2006 Results 115 Jul 19, 2006: Abbott Declares Quarterly Dividend 115 Apr 19, 2006: Abbott Reports Q1 2006 Results 115 Apr 19, 2006: Abbott Declares Quarterly Dividend 116 Corporate Communications 116 Dec 03, 2009: Abbott Lays Off About 80 Jobs At Its Temecula Factory, California 116 Aug 03, 2007: Abbott COO To Retire 117 Dec 20, 2006: Abbott To Voluntarily Delist From NYSE Arca 117 Jan 20, 2006: Abbott Names New Director To The Board 117 Legal and Regulatory 117 Nov 11, 2009: Arnold & Itkin Announces Lawsuits Over Defective Pain Pumps 117 Aug 26, 2009: New Jersey Doctor Files Patent Lawsuit Against Abbott Over Heart Stents 118 Jul 27, 2009: Medtronic And Abbott Resolve Global Vascular Patent Disputes 118 Jun 29, 2009: Centocor Ortho Biotech Awarded $1.67 Billion Patent Jury Verdict From Abbott 118 May 18, 2009: Judge Shot Down Abbott In $200 Million Stent Case 118 Oct 31, 2008: Abbott Files Law Suit Against Medtronic Over Stents 118 Jul 25, 2008: Abbott Gets US Subpoena On Bile-duct Stents 119 Apr 14, 2008: Innogenetics Receives $9.5 Million In Settlement And Licensing Fees From Abbott 119 Government and Public Interest 119 Nov 17, 2009: FDA Warns Abbott On Manufacturing Practices At Des Plaines Facility 119 Nov 16, 2009: Federal Sales Tax On Medical Devices Would Cost Millions 119 Feb 20, 2009: Abbott Obtains European Commission Clearance For Acquisition Of AMO 120 Product News 120 Jan 14, 2010: Abbott Gains CE Mark For New Ovarian Cancer Diagnostic Test 120 Sep 18, 2009: Abbott Receives FDA Approval For Prism HIV O Plus Assay 120 Sep 15, 2009: Abbott Gains Top Honor In Wall Street Journal Technology Innovation Awards For Its PLEX-ID 121 Jul 22, 2009: Abbott Laboratories’ HE4 Diagnostic Marker Test Shows Promise In Monitoring Ovarian Cancer 121 Jul 21, 2009: Abbott Announces The Introduction Of PLEX-ID Molecular Diagnostic System 122 May 12, 2009: XCELL Trial, The First US Trial Of Stent Placement To Study Arterial Blockages Below The Knee Completes Patient Enrollment 122 May 07, 2009: HIV/AIDS Research Network Recommends Abbott’s RealTime HIV-1 Assay And Abbott m2000 System For NIH-Sponsored Clinical Trials 123 Oct 01, 2008: Abbott Files PMA Application To FDA For Market Clearance Of ARCHITECT CORE 123 Apr 22, 2008: Smiths Medical To Promote And Distribute Abbott's FreeStyle Navigator Continuous Glucose Monitoring System 124 Jan 18, 2008: Abbott Announces Approval Of First Fully Automated Blood Screening Test For HTLV-I/HTLV-II 124 Jul 08, 2007: The FreeStyle Navigator Continuous Glucose Monitor Is Approved In Europe 124 Product Approvals 124 Jan 14, 2010: Abbott Gains CE Mark For New Ovarian Cancer Diagnostic Test 124 Sep 18, 2009: Abbott Receives FDA Approval For Prism HIV O Plus Assay 125 Jan 18, 2008: Abbott Announces Approval Of First Fully Automated Blood Screening Test For HTLV-I/HTLV-II 125 Jul 08, 2007: The FreeStyle Navigator Continuous Glucose Monitor Is Approved In Europe 125 Clinical Trials 126 Jul 22, 2009: Abbott Laboratories’ HE4 Diagnostic Marker Test Shows Promise In Monitoring Ovarian Cancer 126 May 12, 2009: XCELL Trial, The First US Trial Of Stent Placement To Study Arterial Blockages Below The Knee Completes Patient Enrollment 126 May 07, 2009: HIV/AIDS Research Network Recommends Abbott’s RealTime HIV-1 Assay And Abbott m2000 System For NIH-Sponsored Clinical Trials 127 Other Significant Developments 127 Jun 23, 2009: Abbott Receives Approval For Xience Prime Drug Eluting Stent 127 Oct 29, 2008: Abbott’s CFO To Present At Annual Credit Suisse Health Care Conference 128 Sep 05, 2008: Abbott’s CFO To Present At Bank of America Conference 128 Sep 05, 2008: Abbott’s VP To Present At UBS Conference 128 May 16, 2008: Abbott Contributes To Disaster Relief Efforts In China And Myanmar 128 Jun 04, 2007: Abbott Signs Agreement With Novation For Diagnostic Equipment And Tests 128 Apr 16, 2007: Abbott And Premier Sign Contract For Diagnostic Tests 129 Appendix 130 Methodology 130 About Global Markets Direct 130 Contact Us 130 Disclaimer 130 [Fade out table of contents] |
||||||||||||
|
List of Tables Abbott Laboratories, Medical Equipment, Key Facts, 2008 1 Abbott Laboratories Acquires Vascular Business Of Guidant From Boston Scientific 15 Advanced Medical Optics Acquires Surgical Ophthalmology Business From Pfizer 16 Evalve Secures $60 Million In Series D Financing 17 Ovalis Secures $6.6 Million In Series B Funding 19 Optobionics Secures $5 Million In Series D-1 Financing 20 Prodesse Enters Into A licensing Agreement With Abbott Laboratories 21 Fujirebio Diagnostics Signs Licensing Agreement With Abbott Laboratories 22 Rubicon Genomics Enters Into An Agreement With Abbott Laboratories 23 Advanced Medical Optics Enters Into An Agreement With Alcon 24 Advanced Medical Optics Enters Into An Agreement With Bausch & Lomb 25 Advanced Medical Optics Signs An Agreement With Carl Zeiss Meditec 26 Epigenomics Signs An Agreement With Abbott Laboratories 27 MacroArray Technologies Enters Into A License Agreement With Abbott 28 Abbott Laboratories Enters Into Licensing Agreement With Advanced Life Science Institute 29 Affymetrix Enters Into Licensing Agreement With Abbott 30 Abbott Laboratories Enters Into Licensing Agreement With Bayer Healthcare 31 Abbott Laboratories Enters Into Licensing Agreement With Nephromics 32 Abbott Laboratories Enters Into Licensing Agreement With BioCurex 33 Abbott Laboratories Enters Into Licensing Agreement With Cleveland Clinic 34 Calypte Biomedical Enters Into An Agreement With Abbott Laboratories 35 Advanced Medical Optics Signs An Agreement With Quest Vision Technologies 36 Abbott Laboratories Enters Into An Agreement With BG Medicine 37 Coherex Medical Enters Into Distribution Agreement With Abbott Laboratories 38 Health Discovery Signs An Agreement With Abbott Laboratories 39 Celera Enters Into An Agreement With Abbott Laboratories 40 Abbott Laboratories Extends Its Distribution Agreement With Axis-Shield 41 Smiths Medical Enters Into An Agreement With Abbott Laboratories 42 Luminex Enters Into A Partnership Agreement With Abbott Laboratories 43 Abbott Laboratories Signs An Agreement With Medica 44 BioView Enters Into An Agreement With Abbott Molecular 45 Abbott Laboratories Enters Into Distribution Agreement With Verax 46 BioVisioN Enters Into Research Agreement With Abbott Laboratories 47 Abbott Laboratories Enters Into An Agreement With Inpeco 48 Nihon Kohden Enters Into Co-Marketing Agreement With Abbott Laboratories 49 Abbott Laboratories Enters Into Co-Marketing Agreement With OraSure 50 Abbott Laboratories Signs An Agreement With Biogenex Laboratories 51 Advanced Medical Optics Enters Into An Agreement With CooperVision 52 Advanced Medical Optics Signs An Agreement With OPHTEC USA 53 Abbott Laboratories Signs An Agreement With Artus 54 Abbott Laboratories Signs An Agreement With Atria Genetics 55 Abbott Laboratories Enters Into An Agreement With Europroteome 56 NeoGenomics Completes Private Placement Of $4.8 Million 57 Zimmer Holdings Acquires Abbott Spine From Abbott Laboratories 58 Inverness Medical Innovations Acquires Rapid Diagnostics Assets From Abbott Laboratories 59 Inverness Medical Acquires Determine Business From Abbott Laboratories 60 Abbott Laboratories Completes Public Offering Of 5.125% Notes For $2,000 Million 61 Abbott Laboratories Completes Public Offering Of 6% Notes For $1,000 Million 62 Abbott Laboratories Completes Public Offering Of Notes Due 2012 For $1,000 Million 63 Abbott Laboratories Completes Public Offering Of Notes Due 2017 For $1,500 Million 64 Abbott Laboratories Completes Public Offering Of Notes Due 2037 For $1,000 Million 65 Advanced Medical Optics Completes Private Placement Of $250 Million 66 Advanced Medical Optics Completes Private Placement Of $500 Million 67 Abbott Laboratories Completes Public Offering Of 5.375% Notes For $500 Million 68 Abbott Laboratories Completes Public Offering Of Notes Due 2011 For $1,500 Million 69 Abbott Laboratories Completes Public Offering Of Notes Due 2016 For $2,000 Million 70 Advanced Medical Optics Completes Private Placement Of $150 Million 72 Abbott Laboratories Completes Public Offering Of Notes Due 2009 For $500 Million 73 Advanced Medical Optics Completes Private Placement Of $350 Million 74 Abbott Laboratories Completes Public Offering Of Notes Due 2014 For $500 Million 75 Abbott Laboratories Completes Public Offering Of Notes Due 2011 For $500 Million 76 Abbott Laboratories Completes Acquisition Of Evalve 77 Abbott Laboratories Completes Acquisition Of Visiogen 78 Abbott Laboratories Acquires Advanced Medical Optics 79 Abbott Laboratories Acquires Ibis Biosciences From Isis Pharmaceuticals 81 Advanced Medical Optics Acquires Intralase 82 Advanced Medical Optics Acquires Wavefront Sciences 84 Advanced Medical Optics Acquires Quest Vision Technologies 85 Advanced Medical Optics Acquires VISX 86 Abbott Laboratories Acquires Spine Next 87 Abbott Laboratories Acquires TheraSense 88 Abbott Laboratories Acquires i-STAT 89 List of Figures Abbott Laboratories, Medical Equipment, Deals By Year, 2004 to YTD 2010 8 Abbott Laboratories, Medical Equipment, Deals by Type, 2004 to YTD 2010 9 Abbott Laboratories, Medical Equipment, Deals By Region, 2004 to YTD 2010 10 Abbott Laboratories, Medical Equipment, Deals by Market, 2004 to YTD 2010 11 [Fade out list of tables / figures] |
||||||||||||
| Price ** (Report format): |
free of shipping costs ** IMPORTANT: All prices are net prices without taxes. Depending on the country in your billing address you have to pay sales taxes. If you have given us your billing adress, VAT No., etc. the correct total amount will be stated in the following order process. More informations on prices and taxes please find in our FAQs. |
|||||||||||
| Notice for this market research report: | * The invoice amount for this study is accounted in $ (dollar). Your bank or your credit card supplier will calculate the topical day course in your currency to you on payment. | |||||||||||
